From: Access to antibiotics in New Delhi, India: implications for antibiotic policy
Antibiotic name | GNCT Delhi | MCD | ||||
---|---|---|---|---|---|---|
Pr. care | Second care | Tertiary care | Pr. care | Second care | Tertiary care | |
(n = 32) | (n = 7) | (n = 1) | (n = 36) | (n = 3) | (n = 1) | |
1. amoxicillin 250 + clavulanic acid$ | 21.9% | 42.9% | Available | 52.8% | 66.7% | Available |
2. Amoxicillin 250# | 71.9% | 57.1% | Available | 19.4% | 33.3% | N.A |
3. Amoxicillin 500# | 81.3% | 85.7% | Available | 30.6% | 66.7% | Available |
4. Amoxicillin suspension# | 62.5% | 100.0% | Available | 5.6% | 0.0% | N.A |
5. Amoxicillin + clavulanic acid | 31.3% | 14.3% | N.A | 58.3% | 66.7% | Available |
Syrup$ | ||||||
6. Ampicillin suspension# | 25.0% | 0.0% | N.A | 2.8% | 0.0% | N.A |
7. Azithromycin@ | 0.0% | 14.3% | Available | 2.8% | 0.0% | N.A |
8. Benzathine Penicillin Powder# | 0.0% | 0.0% | N.A | 0.0% | 0.0% | N.A |
9. Cefixime$ | 21.9% | 14.3% | N.A | 25.0% | 66.7% | Available |
10. Ceftriaxone injection@* | 0.0% | 57.1% | Available | 0.0% | 0.0% | N.A |
11. Cefuroxime axetil@* | 43.8% | 71.4% | N.A | 47.2% | 66.7% | N.A |
12. Cefuroxime suspension@* | 0.0% | 28.6% | N.A | 0.0% | 0.0% | N.A |
13.Cephalexin#* | 43.8% | 71.4% | N.A | 19.4% | 33.3% | N.A |
14. Cephalexin syrup#* | 53.1% | 14.3% | Available | 8.3% | 0.0% | N.A |
15. Ciprofloxacin# | 37.5% | 100.0% | Available | 72.2% | 100.0% | Available |
16. Co-trimoxazole suspension# | 56.3% | 85.7% | Available | 2.8% | 0.0% | N.A |
17. Doxycycline# | 50.0% | 71.4% | Available | 69.4% | 100.0% | Available |
18. Erythromycin powder for suspension# | 40.6% | 42.9% | Available | 0.0% | 0.0% | N.A |
19. Erythromycin stearate# | 43.8% | 57.1% | Available | 0.0% | 0.0% | N.A |
20. Gentamicin eye drops@ | 59.4% | 71.4% | Available | 11.1% | 33.3% | N.A |
21. Gentamicin injection@ | 3.1% | 28.6% | Available | 0.0% | 0.0% | N.A |
22. Norfloxacin# | 84.4% | 85.7% | Available | 2.8% | 0.0% | N.A |
23. Ofloxacin@ | 37.5% | 71.4% | Available | 47.2% | 66.7% | Available |
24. Roxithromycin# | 40.6% | 71.4% | N.A | 8.3% | 0.0% | N.A |